Trial intelligence / Profile preview

Efficacy and Safety of LCS12 and LCS16 for Contraception

NCT00528112Phase 3Completed

Sponsor
Bayer
Start
Aug 2007
Primary completion
Jul 2011
Modality
Small Molecules
Countries
11
01

Overview

A Phase 3 trial of levonorgestrel intrauterine system in contraception, sponsored by Bayer. Started Aug 2007; status: completed.

02

Drugs

levonorgestrel intrauterine system
03

Conditions

contraception

Beyond the preview

Go deeper on NCT00528112.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00528112.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call